AG
IMVT icon

Algert Global’s Immunovant IMVT Stock Holding History

Algert Global’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.16M Buy
159,840
+54,070
+51% +$1.65M 0.07% 446
2026
Q1 		$2.63M Buy
+105,770
New +$2.74M 0.04% 640
2025
Q4 		– Sell
-34,900
Closed -$563K – 1228
2025
Q3 		$563K Buy
+34,900
New +$565K 0.01% 915
2024
Q4 		– Sell
-36,969
Closed -$1.05M – 1243
2024
Q3 		$1.05M Sell
36,969
-83,969
-69% -$2.48M 0.03% 736
2024
Q2 		$3.19M Buy
120,938
+69,278
+134% +$1.97M 0.11% 311
2024
Q1 		$1.67M Buy
51,660
+1,999
+4% +$72.9K 0.07% 472
2023
Q4 		$2.09M Sell
49,661
-13,808
-22% -$508K 0.08% 401
2023
Q3 		$2.44M Sell
63,469
-16,190
-20% -$366K 0.11% 299
2023
Q2 		$1.51M Buy
79,659
+40,470
+103% +$755K 0.07% 501
2023
Q1 		$608K Buy
+39,189
New +$680K 0.03% 775
2022
Q4 		– Sell
-82,741
Closed -$462K – 1197
2022
Q3 		$462K Sell
82,741
-43,459
-34% -$212K 0.03% 825
2022
Q2 		$492K Sell
126,200
-10,127
-7% -$43.7K 0.04% 768
2022
Q1 		$751K Buy
+136,327
New +$849K 0.05% 649
2021
Q3 		– Sell
-28,710
Closed -$303K – 1044
2021
Q2 		$303K Sell
28,710
-38,403
-57% -$536K 0.1% 286
2021
Q1 		$1.08M Buy
+67,113
New +$1.77M 0.34% 101

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Algert Global's IMVT Position: Q2 2026 in Review

Algert Global increased its Immunovant (IMVT) stake by 51% in Q2 2026, buying an estimated $1.65M and bringing the position to 159,840 shares worth $6.16M. The position accounts for 0.07% of the portfolio, ranked #446.

Algert Global first reported a position in IMVT in Q1 2021 and has held it in 15 quarters since. 227 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Algert Global held 159,840 shares of Immunovant worth $6.16M as of Q2 2026.
  • Algert Global bought 54,070 Immunovant shares in Q2 2026, an estimated $1.65M.
  • Immunovant made up 0.07% of Algert Global's portfolio in Q2 2026, its #446 holding.
  • Algert Global first reported a position in Immunovant in Q1 2021 and has held it in 15 quarters since.
  • 227 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.